Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer

Cancer cells release DNA fragments into plasma as circulating free DNA (cfDNA). However, quantitative measurement of tumor‐derived DNA in cfDNA remains challenge. The purpose of this study was to quantitatively assess tumor‐derived DNA in lung cancer patients. By optimizing competitive allele‐specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wenwei, Yang, Yang, Zhang, Longzhen, Yin, Jianxin, Huang, Jingwei, Huang, Lei, Gu, Hua, Jiang, Gening, Fang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430107/
https://www.ncbi.nlm.nih.gov/pubmed/28382702
http://dx.doi.org/10.1002/cam4.980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430107/
https://www.ncbi.nlm.nih.gov/pubmed/28382702
http://dx.doi.org/10.1002/cam4.980

Ejemplares similares